Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry, Hospital Groups Clash Over Future Of OPPS Outlier Provision

This article was originally published in The Gray Sheet

Executive Summary

The American Hospital Association urges the Centers for Medicare & Medicaid Services in Oct. 2 comments to avoid changes to the hospital outpatient prospective payment (OPPS) system's "outlier" provision.

You may also be interested in...



HHS OIG 2002 Work Plan Anticipates Further Review Of GPO Fees

Senate Judiciary/Antitrust, Business Rights and Competition Subcommittee hearings on group purchasing organizations are unlikely to occur this year because Congress remains focused on counterterrorism activities, Hill staffers say.

OPPS "Outlier" Payments: Will They Wax Or Wane By Medicare's Rule?

CMS' proposal to revise the hospital outpatient prospective payment system's (OPPS) outlier policy could prevent those funds from being used to shore up the system's overspent "pass-through" program.

OPPS Proposal Delayed As 70% Pro-Rata Reduction Finds Critics On The Hill

A pro-rata reduction exceeding 70% in Medicare "pass-through" payments, expected to be included in CMS' outpatient prospective payment system (OPPS) proposed rule, is preventing timely release of the document.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015499

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel